Title : Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study.

Pub. Date : 2022 Jan

PMID : 35115740






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Few clinical studies have reported the use of Ibrutinib, a covalent Bruton Tyrosine kinase (BTK) inhibitor, in RR DLBCL. ibrutinib Bruton tyrosine kinase Homo sapiens
2 Few clinical studies have reported the use of Ibrutinib, a covalent Bruton Tyrosine kinase (BTK) inhibitor, in RR DLBCL. ibrutinib Bruton tyrosine kinase Homo sapiens